Gujrathi Sheila's Insider Trades & SAST Disclosures
Gujrathi Sheila's most recent trade in Ventyx Biosciences Inc was a trade of 130,000 Common Stock done at an average price of $2.3 . Disclosure was reported to the exchange on Dec. 23, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gujrathi Sheila.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Purchase of securities on an exchange or from another person at price $ 2.31 per share. | 23 Dec 2024 | 130,000 | 130,000 | - | 2.3 | 300,573 | Common Stock |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Other type of transaction at price $ 0.00 per share. | 05 Nov 2024 | 4,611 | 115,139 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,350 | 8,350 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 2,500 | 110,528 | - | 0 | Common Stock | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Other type of transaction at price $ 0.00 per share. | 29 Feb 2024 | 2,986 | 108,028 | - | 0 | Common Stock | |
| Ventyx Biosciences Inc | Gujrathi Sheila | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2024 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 15,937 | 15,937 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.03 per share. | 30 Mar 2023 | 100,000 | 100,000 | - | 6.0 | 603,000 | Common Stock |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Sale of securities on an exchange or to another person at price $ 33.73 per share. | 30 Mar 2023 | 100,000 | 0 | - | 33.7 | 3,373,240 | Common Stock |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2023 | 100,000 | 662,369 | - | - | Stock Option (Right to Buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 32,987 | 0 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 21,825 | 21,825 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2021 | 277,941 | 277,941 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | 25 Oct 2021 | 32,897 | 0 | - | - | Series A Preferred Stock | ||
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | 25 Oct 2021 | 32,897 | 32,897 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges